
Zydus Lifesciences up nearly 3% after WHO approval for typhoid vaccine
Zydus Lifesciences’ shares rose 2.81% after receiving WHO approval for its indigenously developed typhoid vaccine, ZyVac TCV, making it eligible for UN agency procurement.

Zydus Lifesciences’ shares rose 2.81% after receiving WHO approval for its indigenously developed typhoid vaccine, ZyVac TCV, making it eligible for UN agency procurement.

The board of KPIT Technologies has approved raising up to ₹2,880 crore through a qualified institutions placement (QIP) or any other permissible method, the company…

Shares of Cochin Shipyard had made a record high in July this year at ₹2,979 and from those levels, the stock has corrected over 53%.

NIIT Learning Systems posted a 22% jump in net profit for Q2 FY25, reaching ₹57 crore, while revenue increased 4% on-year, supported by new client…

For financial year 2025, Amber Enterprises expects a 25% revenue growth from the previous financial year and a Return on Capital Employed (RoCE) to be…

Bajaj Finance shares have materially underperformed the Nifty index in the last 12 months. Currently, the stock is trading near the highest point of the…

On the global stage, gold prices are rising amid escalating conflicts in West Asia and uncertainty surrounding the upcoming US elections.

The surge seen in Coforge and Persistent Systems has had a rub-off effect on other Midcap IT names as well such Mphasis, Oracle Financial Services…

The ethanol and bio-based chemicals maker has garnered over ₹166 crore from anchor investors, a day before its issue opened for public subscription. Marquee investors…

JSW Energy Share Price | In a stock exchange filing, the the company said its step-down subsidiary JSW Renew Energy Eleven Ltd has signed a…